Bariatric surgeries are used increasingly to treat overweight and obese patients who have clinically relevant signs and symptoms. Approximately 252,000 bariatric surgeries were performed in the United States in 2018. These procedures can be successful in reversing many adverse syndromes associated with obesity (including type II diabetes, hypertension, joint pain, obstructive sleep apnea, hyperlipidemia, and coronary artery disease ), but there are risks and complications to consider, such as the exacerbation of preexisting nutritional deficiencies and the development of new ones. Some deficiencies present soon after surgery, but the late presentation of nutritional deficiencies can contribute to poor outcomes or devastating complications. Bariatric surgeries that use a restrictive technique may lead to nutritional deficiencies due to low intake, whereas restrictive surgeries combined with malabsorptive techniques, such as Roux-en-Y gastric bypass (RYGB), may lead to nutritional deficiencies due to either low intake or malabsorption. Therefore, long-term monitoring for nutritional deficiencies is indicated following gastric bypass surgeries.
Quick Answers for Clinicians
Bariatric surgeries can be classified as restrictive or malabsorptive. Restrictive procedures reduce the volume or capacity of the stomach. Malabsorptive procedures reduce the amount of calories absorbed by altering the flow of the food. Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the most popular surgeries. SG is a restrictive procedure; RYGB is a dual malabsorptive and restrictive technique. Adjustable gastric binding (AGB) and biliopancreatic diversion (BPD) are also available but account for only a small percentage of bariatric surgeries.
Individuals being considered for bariatric surgery should have a preoperative nutritional assessment to identify deficiencies that may predispose them to higher risk of nutritional deficiencies postsurgery. When possible, these deficiencies should be corrected before surgery. Common testing includes tests for vitamins, folate (ie, vitamin B9), iron, ferritin, and calcium concentrations. See Laboratory Testing for full list of testing to consider.
The same tests used for preoperative assessment are also used postsurgery. The biochemical and nutritional testing schedule varies depending on the type of surgery. Refer to the tables in Monitoring for full schedules.
Indications for Testing
Individuals should be assessed for nutritional status before bariatric surgery and should continue to be monitored postsurgery for nutritional deficiencies.
Laboratory Testing
Preoperative Assessment
Individuals being considered for bariatric surgery should have baseline biochemical and nutritional testing performed to identify deficiencies that may predispose them to a higher risk of deficiencies after surgery; deficiencies should be corrected before surgery when possible. Testing for the following micronutrients should be considered.
Vitamins
Vitamin D and calcium levels should be assessed. Vitamin D, 25-hydroxy is a marker of vitamin D stores in the body and is the preferred test. Vitamin D, 1,25 dihydroxy is indicated for renal disease and other special situations and is less commonly used. Calcium may be reduced due to changes in food preferences. Calcium status can be assessed by measuring levels of ionized calcium in serum or whole blood, whereas urinary calcium (24-hour levels) can identify hypocalcuria.
Vitamin B1 should be measured to evaluate patients for thiamine deficiency. Whole blood specimens are required for accurate analysis. Patients should also be assessed for vitamin B12 deficiency, which may take longer to present due to the body’s ability to maintain large stores of the vitamin. B12 deficiency may result from intrinsic factor decrease and loss of absorptive surface. A serum methyl malonic acid (MMA) test is the recommended test for vitamin B12 deficiency.
Patients should be evaluated for folate (B9) deficiency, which is rarely seen due to consumption of fortified foods. Tests for vitamins A, E, and K should be considered as well.
Trace Elements
Recommended mineral testing includes zinc testing and iron studies. Zinc deficiency is common in patients with obesity and may be linked to metabolic syndrome. Iron studies include laboratory tests for iron, iron binding capacity, and ferritin. Iron deficiency may be present before surgery and may be exacerbated by the loss of absorptive surface and/or changes in food preferences. Ferritin testing can be used to evaluate patients for iron deficiency anemia. Ferritin is the most sensitive marker for iron deficiency anemia, but it may be affected by inflammation. Iron and iron binding capacity testing should be used periodically to verify accuracy of ferritin testing; however, this testing is not as sensitive as ferritin testing.
Copper, magnesium, and phosphorous tests should be considered as well.
Postoperative Monitoring
The postoperative schedule for biochemical and nutritional testing is based on type of surgery: sleeve gastrectomy (SG) or RYGB.
Analyte | Time Postsurgery (mos) | ||||||
---|---|---|---|---|---|---|---|
1 | 3 | 6 | 12 | 18 | 24 | Annually Thereafter | |
Vitamin D | ✔ | ✔ | ✔ | ||||
Calcium | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
Vitamin B1 | ✔ | ✔ | ✔ | ✔ | ✔ | ||
Vitamin B6 | ✔ | ✔ | ✔a | ||||
Vitamin B12 | ✔ | ✔ | ✔ | ✔ | ✔ | ||
Vitamin E | ✔ | ||||||
Zinc | ✔ | ✔ | ✔ | ||||
Iron | ✔ | ✔ | ✔ | ||||
Ferritin | ✔ | ✔ | ✔ | ✔ | ✔ | ||
Magnesium | ✔ | ✔ | |||||
Phosphorous | ✔ | ✔ | ✔ | ||||
Transferrin | ✔ | ✔ | ✔ | ✔ | ✔ | ||
Parathyroid hormone | ✔ | ✔ | ✔ | ✔ | |||
aEvery 2-5 yrs. |
ARUP Laboratory Tests
Quantitative Chemiluminescent Immunoassay
Ion-Selective Electrode/pH Electrode
Quantitative Spectrophotometry
Quantitative High Performance Liquid Chromatography (HPLC)/Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Quantitative Chemiluminescent Immunoassay
Quantitative Chemiluminescent Immunoassay
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Quantitative Chemiluminescent Immunoassay
Quantitative Chemiluminescent Immunoassay
Quantitative High Performance Liquid Chromatography
Quantitative High Performance Liquid Chromatography
Quantitative High Performance Liquid Chromatography
Quantitative Inductively Coupled Plasma-Mass Spectrometry
Quantitative Spectrophotometry
Quantitative Chemiluminescent Immunoassay
Quantitative Inductively Coupled Plasma-Mass Spectrometry
Quantitative Spectrophotometry
Quantitative Inductively Coupled Plasma-Mass Spectrometry
Quantitative Spectrophotometry
Quantitative Electrochemiluminescent Immunoassay
Medical Experts
Frank

References
-
ASMBS - Estimate of Bariatric Surgery Numbers, 2011-2018
American Society for Metabolic and Bariatric Surgery. Estimate of bariatric surgery numbers, 2011-2018. [Published: Jun 2018; Accessed: Nov 2020]
-
31301800
Mohapatra S, Gangadharan K, Pitchumoni CS. Malnutrition in obesity before and after bariatric surgery. Dis Mon. 2020;66(2):100866.
-
24038242
Gletsu-Miller N, Wright BN. Mineral malnutrition following bariatric surgery. Adv Nutr. 2013;4(5):506-517.
-
29518206
Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: an Endocrine Society scientific statement. Endocr Rev. 2018;39(2):79-132.
-
ACOS - Bariatric metabolic surgery: Advances continue
Brethauer S, Herron D, Demaria EJoel, et al. Bariatric metabolic surgery: advances continue. American College of Surgeons. [Accessed: Dec 2020]
-
31682518
Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists - executive summary. Endocr Pract. 2019;25(12):1346-1359.
-
26185175
Weng TC, Chang CH, Dong YH, et al. Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. BMJ Open. 2015;5(7):e006964.
-
29204255
Lupoli R, Lembo E, Saldalamacchia G, et al. Bariatric surgery and long-term nutritional issues. World J Diabetes. 2017;8(11):464-474.
-
33162343
Kim J, Nimeri A, Khorgami Z, et al. Metabolic bone changes after bariatric surgery: 2020 update, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee position statement. Surg Obes Relat Dis. 2020;S1550-7289(20)30561-X. Epub ahead of print.
-
21051578
Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823-4843.
31493139
Ciangura C, Coupaye M, Deruelle P, et al. Clinical practice guidelines for childbearing female candidates for bariatric surgery, pregnancy, and post-partum management after bariatric surgery. Obes Surg. 2019;29(11):3722-3734.
29340660
Livingston EH. Reimagining obesity in 2018: a JAMA theme issue on obesity. JAMA. 2018;319(3):238-240.